Welcome to our dedicated page for ORMAT TECHNOLOGIES SEC filings (Ticker: ORA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ORMAT TECHNOLOGIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ORMAT TECHNOLOGIES's regulatory disclosures and financial reporting.
Ormat Technologies, Inc. (ORA) Form 144 filing discloses a planned sale of 1,072 common shares through Morgan Stanley Smith Barney on 18 June 2025. The shares have an aggregate market value of $91,120. This represents roughly 0.0018 % of Ormat’s 60.66 million shares outstanding, indicating a very small transaction relative to overall float.
The seller, David Granot (relationship to issuer not specified in the filing), previously acquired the shares as restricted stock on 2 November 2023 (311 shares) and 9 May 2024 (761 shares). The filing also lists sales by the same individual during the last three months: 838 shares sold on 14 May 2025 for $61,176 and 112 shares sold on 13 May 2025 for $8,270.
No financial performance data or operational updates are included; the document is limited to disclosure of the proposed insider transaction under SEC Rule 144. Given the modest size of the sale, it is unlikely to have a material impact on ORA’s share price, but investors may nevertheless track insider selling trends for sentiment signals.
Ormat Technologies, Inc. (ORA) filed a Form 144 indicating a proposed insider sale of common stock.
The filing covers 564 shares valued at $47,187 (based on the market price as of the filing) to be executed through Morgan Stanley Smith Barney LLC on or after 18 June 2025 on the NYSE. The shares represent approximately 0.0009 % of the company’s 60,662,626 shares outstanding, signalling an immaterial percentage of equity.
The seller acquired the shares on 18 June 2025 via Stock Appreciation Rights and will pay cash upon exercise. The same individual—identified in the past-3-month sales table as Jessica Woelfel—has already sold 170 shares on 25 March 2025, generating gross proceeds of $12,165.20.
No earnings data, strategic transactions or material corporate developments are disclosed; the form is strictly a notice of intent to sell securities. Given the negligible size relative to the public float, the transaction is unlikely to affect liquidity, control, or valuation for current investors.